Lagente V, Fortes Z B, Garcia-Leme J, Vargaftig B B
Departamento de Farmacologia, Universidade de São Paulo, Brasil.
Braz J Med Biol Res. 1987;20(5):595-7.
Topical application of a standard dose of noradrenaline (NA) to the anesthetized rat mesentery evoked a vasoconstrictor response the latency of which was increased in a dose-dependent way by previous addition of PAF-acether or histamine but not by Lyso-PAF. Lyso-PAF, however, blocked the antagonistic effect of PAF-acether to NA, the blockade being equivalent to that observed with PAF-antagonists (BN 52021 or WEB 2086) either injected iv, or applied topically. In contrast, the antagonistic action of histamine towards NA was not affected by Lyso-PAF or PAF-antagonists. Since platelet aggregation and leukocyte accumulation did not occur, PAF-acether appears to interact directly with microvessels to block vasoconstrictor stimuli, an effect antagonized by PAF-antagonists and the metabolite/precursor, Lyso-PAF.
将标准剂量的去甲肾上腺素(NA)局部应用于麻醉大鼠的肠系膜,可诱发血管收缩反应,其潜伏期会因预先添加血小板活化因子(PAF - 乙酰醚)或组胺而呈剂量依赖性增加,但溶血PAF不会产生这种影响。然而,溶血PAF可阻断PAF - 乙酰醚对NA的拮抗作用,这种阻断作用与静脉注射或局部应用PAF拮抗剂(BN 52021或WEB 2086)所观察到的作用相当。相比之下,组胺对NA的拮抗作用不受溶血PAF或PAF拮抗剂的影响。由于未发生血小板聚集和白细胞积聚,PAF - 乙酰醚似乎直接与微血管相互作用以阻断血管收缩刺激,PAF拮抗剂和代谢产物/前体溶血PAF可拮抗这种作用。